Abstract
Background
Sentinel lymph node (SLN) positivity is an important prognostic factor in cutaneous melanoma. A nomogram has been developed at Memorial Sloan-Kettering Cancer Centre (MSKCC) to predict SLN positivity and this may be useful to select patients for SLN biopsy.
Aims
We aimed to determine whether this nomogram would be of clinical use in an Irish population.
Methods
Age, Breslow thickness, Clark’s level, presence of ulceration and tumour location indices were used to calculate the probability of SLN positivity with the MSKCC nomogram in 124 patients who underwent SLN biopsy in Beaumont Hospital between 2006 and 2012. Discrimination and calibration of the nomogram were evaluated. Negative predictive value (NPV) of the nomogram was calculated, using a cut-off of nomogram predicted probability of <9 %.
Results
SLN biopsy was positive in 25 patients (20.16 %). Overall predictive accuracy of the nomogram was found to be significant with an area under the curve of 0.805 (95 % confidence interval 0.710–0.899). The mean predicted probability correlated well with observed risk (r = 0.887). The NPV was 92.86 % with an error rate of 3.23 %. This would lead to a reduction in SLN biopsy rate of 45.16 %.
Conclusions
This nomogram is valid and accurate at predicting SLN positivity in an Irish population. This may facilitate the clinical decision to perform a SLN biopsy in malignant melanoma.
Similar content being viewed by others
References
NCRI (2010) National Cancer Registry Ireland—Online Cancer Incidence. http://www.ncri.ie/data.cgi/client/choose_specific.php?statistic=3001103&search=Search+Text&q. Accessed 29 June 2013
Forsea AM, Del Marmol V, de Vries E et al (2012) Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol 167:1124–1130
Doubrovsky A, De Wilt JH, Scolyer RA et al (2004) Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 11:829–836
Phan GQ, Messina JL, Sondak VK, Zager JS (2009) Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control J Moffitt Cancer Cent 16:234–239
Morton DL (2012) Overview and update of the phase III multicenter selective lymphadenectomy trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 29:699–706
Bleicher RJ, Essner R, Foshag LJ et al (2003) Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 21:1326–1331
Jacobs IA, Chang CK, DasGupta TK, Salti GI (2003) Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma. Ann Surg Oncol 10:558–561
Testori A, De Salvo GL, Montesco MC et al (2009) Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 16:2018–2027
Thompson JF, Scolyer RA, Kefford RF (2005) Cutaneous melanoma. Lancet 365:687–701
Wong SL, Kattan MW, McMasters KM, Coit DG (2005) A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol 12:282–288
White RL Jr, Ayers GD, Stell VH et al (2011) Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol 18:3593–3600
Piñero A, Canteras M, Ortiz E et al (2008) Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma. Ann Surg Oncol 15:2874–2877
Pasquali S, Mocellin S, Campana LG et al (2011) Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. Eur J Surg Oncol 37:675–680
Vergouwe Y (2003) Validation of Clinical Prediction Models: Theory and Applications in Testicular Germ Cell Cancer. Thesis, Erasmus University Rotterdam
Morton DL, Thompson JF, Cochran AJ et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599–609
Sabel MS, Rice JD, Griffith KA et al (2012) Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy. Ann Surg Oncol 19:287–293
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Woods, J.F.C., De Marchi, J.A., Lowery, A.J. et al. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population. Ir J Med Sci 184, 769–773 (2015). https://doi.org/10.1007/s11845-014-1166-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-014-1166-4